{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:01:48Z","timestamp":1786993308437,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jsbmb.2026.106972","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T16:07:34Z","timestamp":1772122054000},"page":"106972","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Serendipity, steroids and science"],"prefix":"10.1016","volume":"260","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1281-3474","authenticated-orcid":false,"given":"Nima","family":"Sharifi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2026.106972_bib1","doi-asserted-by":"crossref","first-page":"13728","DOI":"10.1073\/pnas.1107898108","article-title":"Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer","volume":"108","author":"Chang","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2026.106972_bib2","doi-asserted-by":"crossref","first-page":"17404","DOI":"10.1016\/S0021-9258(19)85349-8","article-title":"Characterization of Chinese hamster ovary cell lines expressing human steroid 5 alpha-reductase isozymes","volume":"268","author":"Thigpen","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2026.106972_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0960-0760(90)90381-T","article-title":"Androstenedione is an important precursor of dihydrotestosterone in the genital skin of women and is metabolized via 5 alpha-androstanedione","volume":"37","author":"Stanczyk","year":"1990","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2026.106972_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1515\/HMBCI.2011.007","article-title":"Assessment of steroidogenic pathways that do not require testosterone as intermediate","volume":"5","author":"Luu-The","year":"2011","journal-title":"Horm. Mol. Biol. Clin. Investig."},{"key":"10.1016\/j.jsbmb.2026.106972_bib5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/s41585-021-00433-9","article-title":"Kicking the dirt in the hunt for discoveries: pursuing a career in biomedical science","volume":"18","author":"Sharifi","year":"2021","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jsbmb.2026.106972_bib6","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.cell.2013.07.029","article-title":"A gain-of-function mutation in DHT synthesis in castration-resistant prostate cancer","volume":"154","author":"Chang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.jsbmb.2026.106972_bib7","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1210\/en.2019-00366","article-title":"HSD3B1 genotypes conferring adrenal-restrictive and adrenal-permissive phenotypes in prostate cancer and beyond","volume":"160","author":"Sabharwal","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2026.106972_bib8","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1200\/JCO.2007.15.9749","article-title":"Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven","volume":"26","author":"Attard","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2026.106972_bib9","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S1470-2045(16)30227-3","article-title":"HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study","volume":"17","author":"Hearn","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jsbmb.2026.106972_bib10","article-title":"HSD3B1, prostate cancer mortality and modifiable outcomes","author":"Freitas","year":"2024","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.jsbmb.2026.106972_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmed.2025.07.004","article-title":"Prostate cancer germline variants with therapeutic implications","author":"Bitaraf","year":"2025","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jsbmb.2026.106972_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.2976","article-title":"Adrenal-permissive germline HSD3B1 allele and prostate cancer outcomes","volume":"7","author":"McKay","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jsbmb.2026.106972_bib13","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.3402","article-title":"Adrenal-permissive HSD3B1 genotype-an invisible stimulator of prostate cancer mortality","volume":"7","author":"Schiffer","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jsbmb.2026.106972_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163498","article-title":"BMX controls 3betaHSD1 and sex steroid biosynthesis in cancer","volume":"133","author":"Li","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2026.106972_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2422267122","article-title":"Fine structural design of 3betaHSD1 inhibitors for prostate cancer therapy","volume":"122","author":"He","year":"2025","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2026.106972_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.6496","article-title":"HSD3B1 genotype and clinical outcomes in metastatic castration-sensitive prostate cancer","volume":"6","author":"Hearn","year":"2020","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.jsbmb.2026.106972_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/JCI183583","article-title":"Survival of men with metastatic hormone-sensitive prostate cancer and adrenal-permissive HSD3B1 inheritance","volume":"134","author":"Sharifi","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jsbmb.2026.106972_bib18","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1073\/pnas.1918819117","article-title":"HSD3B1 genotype identifies glucocorticoid responsiveness in severe asthma","volume":"117","author":"Zein","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jsbmb.2026.106972_bib19","doi-asserted-by":"crossref","first-page":"7194","DOI":"10.1245\/s10434-022-12088-w","article-title":"Association of HSD3B1 genotype and clinical outcomes in postmenopausal estrogen-receptor-positive breast cancer","volume":"29","author":"Flanagan","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.jsbmb.2026.106972_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.150403","article-title":"Adrenal-permissive HSD3B1 genetic inheritance and risk of estrogen-driven postmenopausal breast cancer","volume":"6","author":"Kruse","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.jsbmb.2026.106972_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkac061","article-title":"Association between adrenal-restrictive HSD3B1 inheritance and hormone independent subtypes of endometrial and breast cancer","author":"McManus","year":"2022","journal-title":"JNCI Cancer Spectr."},{"key":"10.1016\/j.jsbmb.2026.106972_bib22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1146\/annurev-med-051418-060357","article-title":"Sex hormones and prostate cancer","volume":"71","author":"Auchus","year":"2020","journal-title":"Annu Rev. Med"},{"key":"10.1016\/j.jsbmb.2026.106972_bib23","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1014618","article-title":"Abiraterone and increased survival in metastatic prostate cancer","volume":"364","author":"de Bono","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2026.106972_bib24","article-title":"Abiraterone in metastatic prostate cancer without previous chemotherapy","author":"Ryan","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2026.106972_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1056\/NEJMoa1702900","article-title":"Abiraterone for prostate cancer not previously treated with hormone therapy","volume":"377","author":"James","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2026.106972_bib26","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1056\/NEJMoa1704174","article-title":"Abiraterone plus prednisone in metastatic, castration-sensitive prostate cancer","volume":"377","author":"Fizazi","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jsbmb.2026.106972_bib27","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.53.4578","article-title":"Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study","author":"Taplin","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jsbmb.2026.106972_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1177\/1758834016642370","article-title":"CYP17 inhibitors in prostate cancer: latest evidence and clinical potential","volume":"8","author":"Alex","year":"2016","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.jsbmb.2026.106972_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-66558-2","article-title":"A bypass gateway from cholesterol to sex steroid biosynthesis circumnavigates CYP17A1","volume":"16","author":"Zhu","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jsbmb.2026.106972_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104841","article-title":"Processive kinetics in the three-step lanosterol 14alpha-demethylation reaction catalyzed by human cytochrome P450 51A1","volume":"299","author":"McCarty","year":"2023","journal-title":"J. Biol. Chem."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000385?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076026000385?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T02:55:03Z","timestamp":1777949703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076026000385"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":30,"alternative-id":["S0960076026000385"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.106972","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serendipity, steroids and science","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2026.106972","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106972"}}